These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 3342288)

  • 1. Pharmacokinetics of 8-methoxypsoralen in the dog.
    Monbaliu JG; Belpaire FM; Braeckman RA; Bogaert MG
    Biopharm Drug Dispos; 1988; 9(1):9-17. PubMed ID: 3342288
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study of the bioavailability of different formulations of 8-methoxypsoralen in the dog.
    Monbaliu JG; Belpaire FM; Bogaert MG
    Biopharm Drug Dispos; 1988; 9(1):1-8. PubMed ID: 3342281
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High plasma levels of 8-methoxypsoralen following bath water delivery in dermatological patients.
    Kappes UP; Barta U; Merkel U; Balogh A; Elsner P
    Skin Pharmacol Appl Skin Physiol; 2003; 16(5):305-12. PubMed ID: 12907835
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of 8-methoxypsoralen following i.v. administration in humans.
    Billard V; Gambus PL; Barr J; Minto CF; Corash L; Tessman JW; Stickney JL; Shafer SL
    Br J Clin Pharmacol; 1995 Oct; 40(4):347-60. PubMed ID: 8554937
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Pharmacokinetics and metabolite-pattern of 8-methoxypsoralen in man following oral administration as compared to the pharmacokinetics in rat and dog.
    Busch U; Schmid J; Koss FW; Zipp H; Zimmer A
    Arch Dermatol Res; 1978 Aug; 262(3):255-65. PubMed ID: 718254
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Kinetics of 8-methoxypsoralen and 5-methoxypsoralen distribution in guinea pig serum, epidermis and ocular lens.
    Wamer W; Giles A; Kornhauser A
    Photodermatol; 1987 Oct; 4(5):236-9. PubMed ID: 3697346
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Metabolism of the anti-psoriatic agent 5-methoxypsoralen in humans: comparison with rat and dog.
    John BA; Chasseaud LF; Wood SG; Forlot P
    Xenobiotica; 1992 Nov; 22(11):1339-51. PubMed ID: 1492426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Determination of 8-methoxypsoralen in mouse plasma by high performance liquid chromatography and its application to pharmacokinetic study].
    Wu TW; Cui R; Zhang BX
    Beijing Da Xue Xue Bao Yi Xue Ban; 2018 Oct; 50(5):792-796. PubMed ID: 30337737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The pharmacokinetics of HI-6 in beagle dogs.
    Simons KJ; Briggs CJ
    Biopharm Drug Dispos; 1983; 4(4):375-88. PubMed ID: 6661515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The pharmacokinetics of penicillamine in a female mongrel dog.
    Bergstrom RF; Kay RD; Wagner JG
    J Pharmacokinet Biopharm; 1981 Oct; 9(5):603-21. PubMed ID: 7334461
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics of selamectin following intravenous, oral and topical administration in cats and dogs.
    Sarasola P; Jernigan AD; Walker DK; Castledine J; Smith DG; Rowan TG
    J Vet Pharmacol Ther; 2002 Aug; 25(4):265-72. PubMed ID: 12213114
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interspecies pharmacokinetic scaling of oltipraz in mice, rats, rabbits and dogs, and prediction of human pharmacokinetics.
    Bae SK; Lee SJ; Kim YG; Kim SH; Kim JW; Kim T; Lee MG
    Biopharm Drug Dispos; 2005 Apr; 26(3):99-115. PubMed ID: 15723427
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Toxicokinetics of methyl paraoxon in the dog.
    De Schryver E; De Reu L; Belpaire F; Willems J
    Arch Toxicol; 1987 Feb; 59(5):319-22. PubMed ID: 3579595
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disposition of 8-methoxypsoralen in the rat: methodology for measurement, dose-dependent pharmacokinetics, tissue distribution and identification of metabolites.
    Mays DC; Rogers SL; Guiler RC; Sharp DE; Hecht SG; Staubus AE; Gerber N
    J Pharmacol Exp Ther; 1986 Feb; 236(2):364-73. PubMed ID: 3944766
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetics and disposition of the oxytocin receptor antagonist L-368,899 in rats and dogs.
    Thompson KL; Vincent SH; Miller RR; Colletti AE; Alvaro RF; Wallace MA; Feeney WP; Chiu SH
    Drug Metab Dispos; 1997 Oct; 25(10):1113-8. PubMed ID: 9321512
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [5-Methoxypsoralen: bioavailability and pharmacokinetics].
    Nitsche V; Mascher H
    Arzneimittelforschung; 1982; 32(10):1338-41. PubMed ID: 6891237
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of metoclopramide on the pharmacokinetics of 8-methoxypsoralen.
    Studer-Sachsenberg EM; Piletta PA; Fathi M; Saurat JH; Salomon D
    Dermatology; 1997; 195(1):81-3. PubMed ID: 9267751
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Excretion and tissue distribution of 14C-labelled 8-methoxypsoralen in beagle dogs and miniature pigs.
    Ikeda GJ; Sapienza PP; Sager AO; Kornhauser A
    Food Chem Toxicol; 1990 May; 28(5):333-8. PubMed ID: 2379892
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Plasma and skin concentration of 5-methoxypsoralen in psoriatic patients after oral administration.
    Zucchi A; Raho E; Marconi B; Nicoli S; Santini M; Allegra F; Colombo P; Bettini R; Santi P
    J Invest Dermatol; 2001 Aug; 117(2):379-82. PubMed ID: 11511320
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraindividual variations of 8-methoxypsoralen plasma levels.
    Schäfer-Korting M; Korting HC
    Arch Dermatol Res; 1982; 272(1-2):1-7. PubMed ID: 7165313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.